Q: Can you tell us a little about your background?

A: I have been involved with R & D for more than 34 years, including 18 years in the nutraceutical business. I received my doctorate in biochemistry and nutrition at Virginia Polytechnic Institute and State University. After that, I was a NIH post-doctorate research fellow at Duke University Medical Center, specializing in free radical biochemistry. I also was a Pratt research fellow, specializing in nutrition. I have published more than 60 papers in peer-reviewed scientific journals and have served as a member of the editorial board of Journal of Advancement of Medicine.

Q: How did your interest in Sytrinol arise?

A: More than 64 million Americans require support for cardiovascular health. Because up to 80% of the body's cholesterol is produced by the liver, I thought it was interesting to find natural ingredients that help the liver to maintain healthy lipid metabolism.

Q: What is Sytrinol™ composed of and how was it developed?

A: Sytrinol™ is a patented formula derived from citrus fruit and orange peel as well as palm fruit extract, providing polymethoxylated flavones (PMFs) and tocotrienols. PMFs are a subclass of bioflavonoids found in citrus fruits that possess an extra methyl group, making them highly biologically active. The two most common and bioactive PMFs are tangeretin and nobilietin. While each of these constituents has heart health potential, scientists discovered that combining them provided a synergistic effect. Sytrinol was developed after twelve years of research, including the evaluation and screening of over 250 test tube, pharmacological and human clinical studies on PMFs and palm tocotrienols.

Q: What distinguishes Sytrinol from other natural products for lipid and triglyceride health?

A: The basis of Sytrinol is to maintain healthy endogenous lipid production dictated by genetic disposition rather than to moderate the absorption of lipids from food. In addition to providing beneficial support for overall healthy lipid metabolism and triglyceride levels, Sytrinol specifically moderates apoprotein B and supports apoprotein A1 production. Furthermore, studies suggest that Sytrinol may maintain healthy C-reactive protein metabolism. On top of these main actions, Sytrionl provides antioxidant support, promotes healthy immune response in the arterial vessel walls and encourages healthy blood flow.

Q: What are the results of the recent clinical trials involving Sytrinol?

A: The first clinical trial consisted of 60 adults who took 300 mg Sytrinol daily for 4 weeks. Results suggest statistically significant support for lipid and triglyceride metabolism. In the second trial, 10 adults also reported similar benefits after 4 weeks supplementation, including moderation of apoprotein B and enhancement of apoprotein A1 synthesis. The third clinical trial was a 12-week placebo controlled study involving 120 volunteers, which further corroborated the results of the previous trials.

Q: Is Sytrinol safe? Are there any contraindications?

A: No adverse effects have been reported in clinical studies at the recommended daily intake amounts. Animal toxicity studies indicate a maximum tolerated dose greater than 14 grams. However, because Sytrinol contains tocotrienols, it may not be advised for people on blood thinning medications.

The information contained herein is for informational purposes only and does not establish a doctor-patient relationship. Please be sure to consult your physician before taking this or any other product. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.